Jun 16, 2020
Endo to Announce Second-Quarter 2020 Financial Results
May 14, 2020
Endo to Participate at 2020 RBC Capital Markets Global Healthcare Virtual Conference
Apr 16, 2020
Endo to Announce First Quarter 2020 Financial Results
Mar 26, 2020
DotLab, a molecular diagnostics company, announces the publication of the clinical validation study for its non-invasive test for endometriosis
Jan 24, 2020
Endo to Announce Fourth-Quarter and Full-Year 2019 Financial Results
Jan 10, 2020
Endo Settles Opioid Investigation with State of Oklahoma for $8.75 million
Dec 17, 2019
Endo to Participate at J.P. Morgan Healthcare Conference
Dec 10, 2019
Endo Launches Generic Version of Afinitor® (everolimus) Tablets in the United States
Nov 22, 2019
Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference
Oct 28, 2019
Endo Aesthetics Launches New Campaign Elevating Artistry Through Scientific Innovation
Sep 30, 2019
Endo Announces Successful Culmination of Litigation Regarding FDA Compounding Policy
Aug 20, 2019
Endo Announces Settlement in Principle to Resolve "Track 1" Opioid Cases
Jul 11, 2019
Endo to Announce Second-Quarter 2019 Financial Results
May 15, 2019
Endo to Participate at RBC Healthcare Conference
Apr 10, 2019
Endo to Announce First-Quarter 2019 Financial Results
Mar 14, 2019
Endo International plc Announces Pricing of Private Offering Of Senior Secured Notes
Mar 04, 2019
Endo to Participate at Cowen & Company 39th Annual Healthcare Conference
Mar 01, 2019
Endo Will Showcase Late-Breaking Phase 3 CCH Data at the 2019 American Academy of Dermatology Annual Meeting
Mar 01, 2019
Endo Announces FDA Decision Not to Include Vasopressin on 503B Bulks List
Feb 27, 2019
Endo Announces Termination of Acquisition Agreements with Somerset Therapeutics and Business of Affiliate Wintac Limited